Early limited antiretroviral therapy is superior to deferred therapy in HIV-infected South African infants: results from the CHER (Children with HIV Early antiRetroviral) Randomized Trial

Παρόμοια τεκμήρια

• Early Antiretroviral Therapy reduces the incidence of otorrhea in a randomized study of early and deferred antiretroviral therapy: Evidence from the Children with HIV Early Antiretroviral Therapy (CHER) Study
  ανά: Hainline, Clotilde, κ.ά.
  Έκδοση: (2011)
• Reactivity of routine HIV antibody tests in children who initiated antiretroviral therapy in early infancy as part of the Children with HIV Early Antiretroviral Therapy (CHER) trial
  ανά: Payne, H, κ.ά.
  Έκδοση: (2015)
• Thymic Output and CD4 T-Cell Reconstitution in HIV-Infected Children on Early and Interrupted Antiretroviral Treatment: Evidence from the Children with HIV Early Antiretroviral Therapy Trial
  ανά: Lewis, Joanna, κ.ά.
  Έκδοση: (2017)
• Five year neurodevelopment outcomes of perinatally HIV‐infected children on early limited or deferred continuous antiretroviral therapy
  ανά: Laughton, Barbara, κ.ά.
  Έκδοση: (2018)
• Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis
  ανά: Rabie, H., κ.ά.
  Έκδοση: (2011)